Table II.
Haematological recovery and toxicity in the three groups of patients (i.e., anti-IL-6, DEX and HDM140, HDM140 and HDM200).
HDM= High dose melphalan
Patients having anti-IL-6 mAb before high dose melphalan were hospitalized 4 additional days because of a Phase II protocol, avoiding any clinical problem.